Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M47.7Revenue $M34.5Net Margin (%)80.2Z-Score23.1
Enterprise Value $M38.8EPS $0.4Operating Margin %77.3F-Score7
P/E(ttm))1.9Cash Flow Per Share $-0.3Pre-tax Margin (%)79.6Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %0Quick Ratio27.5Cash flow > EarningsN
Price/Sales1.45-y EBITDA Growth Rate %0Current Ratio27.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %500ROA % (ttm)158Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)180Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M44.1ROI % (ttm)1.9Gross Margin Increase y-yN

Gurus Latest Trades with ENZN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZNGeorge Soros 2014-06-30 Buy $0.81 - $1.18
($0.95)
$ 1.1723%New holding, 50123 sh.50,123
ENZNSeth Klarman 2014-03-31 Sold Out -0.14%$0.861 - $1.26
($1.04)
$ 1.1712%Sold Out0
ENZNSeth Klarman 2013-12-31 Reduce-0.16%$1.15 - $1.74
($1.54)
$ 1.17-24%Reduce -43.6%4,337,858
ENZNCharles Brandes 2013-06-30 Add0.02%$1.6 - $3.95
($2.93)
$ 1.17-60%Add 184.52%1,026,723
ENZNCharles Brandes 2013-03-31 Add0.01%$3.79 - $4.99
($4.54)
$ 1.17-74%Add 432.17%360,865
ENZNCharles Brandes 2012-12-31 Add$4.35 - $7
($6.03)
$ 1.17-81%Add 35.19%67,810
ENZNJean-Marie Eveillard 2012-12-31 Sold Out -0.01%$4.35 - $7
($6.03)
$ 1.17-81%Sold Out0
ENZNJean-Marie Eveillard 2012-09-30 Reduce-0.02%$6.42 - $7.17
($6.8)
$ 1.17-83%Reduce -56.42%490,142
ENZNCharles Brandes 2012-06-30 Add$5.87 - $7.06
($6.44)
$ 1.17-82%Add 58.41%51,070
ENZNCharles Brandes 2012-03-31 Buy $6.54 - $7.82
($6.67)
$ 1.17-82%New holding, 32240 sh.32,240
ENZNCarl Icahn 2011-09-30 Add0.07%$7.24 - $10.37
($8.8)
$ 1.17-87%Add 25%5,904,863
ENZNRichard Perry 2011-09-30 Sold Out -0.5937%$7.24 - $10.37
($8.8)
$ 1.17-87%Sold Out0
ENZNGeorge Soros 2011-06-30 Sold Out $9.97 - $11.81
($10.79)
$ 1.17-89%Sold Out0
ENZNRichard Perry 2011-06-30 Reduce-0.31%$9.97 - $11.81
($10.79)
$ 1.17-89%Reduce -30.35%2,013,000
ENZNMichael Price 2011-03-31 Add0.16%$10.14 - $12.48
($11.15)
$ 1.17-90%Add 16.65%700,000
ENZNGeorge Soros 2011-03-31 Reduce$10.14 - $12.48
($11.15)
$ 1.17-90%Reduce -52.5%30,400
ENZNCarl Icahn 2010-12-31 Add0.41%$10.5 - $12.5
($11.36)
$ 1.17-90%Add 67.7%4,723,891
ENZNSeth Klarman 2010-09-30 Add0.14%$10.25 - $11.28
($10.74)
$ 1.17-89%Add 2.03%10,382,698
ENZNGeorge Soros 2010-09-30 Add0.01%$10.25 - $11.28
($10.74)
$ 1.17-89%Add 481.74%66,900
ENZNSeth Klarman 2010-06-30 Add0.78%$10.07 - $11.45
($10.67)
$ 1.17-89%Add 10.57%10,175,898
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ENZN George Soros 2014-06-3050,1230.110New Buy
ENZN Michael Price 2014-06-30748,2001.70.1
ENZN Carl Icahn 2014-06-305,904,86313.390.02
ENZN Charles Brandes 2014-06-301,043,3632.370.01-0.48%
Premium Most recent portfolio changes are included for Premium Members only!


ENZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEBUHN ROBERTDirector 2013-09-19Sell55,926$1.72-26.74view
LEBUHN ROBERTDirector 2012-08-14Sell5,820$6.58-80.85view
LEBUHN ROBERTDirector 2012-08-10Sell1,933$6.58-80.85view
HEBARD GEORGEInterim PEO and Interim COO 2012-06-20Buy5,000$6.88-81.69view
Rackear Andrew D.VP and General Counsel 2012-06-05Sell1,614$6.81-81.5view
Conover CharlesSVP, R&D Program Management 2012-06-05Sell25,000$6.78-81.42view
Young Richard ADirector 2012-03-15Sell2,000$6.92-81.79view
Rackear Andrew D.VP and General Counsel 2011-11-10Sell3,766$6.68-81.14view
Buchbinder AbyVP, Clinical Development 2011-11-08Sell2,700$7.06-82.15view
LEBUHN ROBERTDirector 2011-06-01Sell8,702$10.57-88.08view

Press Releases about ENZN :

    Quarterly/Annual Reports about ENZN:

    News about ENZN:

    Articles On GuruFocus.com
    Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
    GuruFocus Real Time Picks of the Week Jan 10 2014 
    Seth Klarman Buys New Stock Kindred Biosciences, Cut Stake in Enzon Jan 10 2014 
    Billionaires Hold Bargains, 40% Off or More Sep 11 2013 
    Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
    First Pacific Advisors’ Top New Buys Aug 08 2012 
    Enzon Inc. Reports Operating Results (10-K) Mar 16 2011 
    Carl Icahn Buys NAV, CHK, ENZN, AMLN, CMC, Feb 15 2011 
    Despite Bearish View, Seth Klarman Holds These Stocks: VSAT, THRX, NWSA, BBEP, ENZN, CSE Nov 25 2010 
    Enzon Inc. Reports Operating Results (10-Q) Nov 04 2010 

    More From Other Websites
    ENZON PHARMACEUTICALS INC Financials Aug 19 2014
    ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
    Enzon regains compliance with Nasdaq Jul 16 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jul 16 2014
    Enzon Pharmaceuticals Inc Stock Upgraded (ENZN) Jul 08 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Jun 12 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... May 30 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events May 19 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... May 09 2014
    ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 09 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material... May 01 2014
    Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards May 01 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Mar 25 2014
    ENZON PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 14 2014
    Warning! Enzon Pharmaceuticals Is Definitely Going To $0 Jan 14 2014
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other... Dec 16 2013
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 05 2013
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Nov 21 2013
    ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 12 2013
    ENZON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other... Oct 22 2013

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    BasseyeNet@twitter
    ReplyBasseyeNet@twitter - 2 weeks ago
    Tangible Book Value:

    $ 0.47 Add to Fair Value


    Growth Value:$ 5.53


    Terminal Value: $ 3.47


    = Fair Value: $ 9
    BasseyeNet@twitter
    ReplyBasseyeNet@twitter - 2 weeks ago
    George Soros (Trades, Portfolio) just joined Carl Icahn (Trades, Portfolio) 2 months ago by adding ENZN to his portfolio...The 1yr price target is $14 on Yahoo finance.. Link below is a breakdown of the Billionaire's holding and adding to there positions in this company.

    http://www.gurufocus.com/gurutrades/ENZN#hold
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK